F. Pearl McBroom, MD Inc.
Internal Medicine, Cardiology and Preventive Medicine 3/18/00
PRELIMINARY CLINICAL OBSERVATIONS ON THE USE OF CENOGENESIS [renamed Regenesis Plus]. A 320 NG PER SPRAY SUBLINGUAL ORAL SPRAY PROVIDED BY REGENESIS
In February, 2000 F. Pearl McBroom, MD, Internist, Cardiologist, Preventive Medicine Specialist, Graduate of the University of Chicago, Columbia College of Physicians & Surgeons, UCLA and University of Southern California, began noting clinical responses to the use of Cenogenesis. It is the highest potency oral Growth Hormone product provided by Regenesis, a pioneer in the field of sublingual Growth Hormone. It provides delivery of 320ng per spray of Growth Hormone delivered orally with maximum suggested 3-4 times daily. Dose is dependent on the initial Insulin Growth Factor (IGF-1) or Somatomedin C Endogenous Growth Hormone levels.
There were ten patients observed between January and March, 2000 who started on Cenogenesis on dates indicated below:
J.C. -54 years old- caucasian female, Somatomedin C (IGF-1) level 167 ng/ml (114-492 normal range). A former gifted schoolteacher with Chronic Viremia and Chronic Fatigue Syndrome and Fibromyalgia, she was unable to work in the past 4 years, during which time she had gained 30 pounds. Within one week on Cenogenesis she lost 10 pounds. During the ensuing month, despite her continued complaint of Chronic Fatigue and Fibromyalgia, she planned and administered a huge birthday celebration gala for her mother, took on a 5 day per week child sitting job with 2 children and drove round trip to San Francisco. These activities represented a major feat in energy requirement for her despite her symptom chronically.
O.P. -43 years old- negro male chauffeur, IGF-1 140 ng/ml (normal 90-360) with Chronic Viremias, Chronic Fatigue Syndrome, residuals of left knee endoscopic surgery and left ankle sprain. Despite these syndromes, he was actively and effectively functioning as a full time chauffeur. Within 24 hours of starting Cenogenesis on January 6, 2000, his energy level soared and in March, 2000 not only completed the L.A. City Marathon but coached another entrant, enabling him to complete the Marathon as well.
M.P. -59 years old- caucasian female exhibiting artist, IGF-1 (Somatomedin C) level 126 (normal 116-270) with severe depression and fatigue was started on Cenogenesis on February 10, 2000. Within two weeks she was in high tone and energetic in a fashion she had never experienced. Her painting artistry was directly inspired.
S.T. -63 years old - minister, Somatomedin C (IGF-1) 94 (normal range (116-270)) with complaint of fatigue and depression. Started on Cenogenesis on February 16, 2000. Within 48 hours she notified us of her resurgence of energy and improved sense of well being.
A.H. –89 years old - black female, mother of S.T. (see above), whose chief problem was Alzheimer’s Syndrome. At Dr. McBroom’s suggestion S.T. gave her mother one spray (320 ng/spray) per day beginning February 16, 2000. Within 24 hours the patient, who had been incoherent, was speaking full sentences and has continued to do so now for 2 months. She is the rage of her community. Members of her church could not believe her transformation. Dr. McBroom has seen dramatic improvement in patients with Alzheimer’s Syndrome and Senile Dementia taking Regenesis products.
J.C.R. - 38 years old- negro female, IGF-1 (Somatomedin-C) 335, complaining of Hypomenorrhea with Menses since onset only 3 or 4 times per year with high hormone levels. She was started on Regenesis Pro August 26, 1999. She became pregnant approximately 4 ½ months after starting Regenesis Pro. She terminated the pregnancy March 13, 2000 and consequently developed postpartum depression. When she was seen on March 16, 2000, she was tearful, anxious, and fearful. She was given one spray of Cenogenesis in the office and was treated for acupoint balancing. She left the office in high tone and good spirits. She has continued so in the past week.
D.M. -37 years old- black female with severe Dysmenorrhea starting 2-5 days before Menses. She began having mild Dysmenorrhea 5 days before the Menses and was given one spray of Cenogenesis the evening of 5th day before Menses, one spray the fourth day before Menses and two sprays the third day before Menses. Ordinarily she would be having profound cramping by then. However, with the Cenogenesis, she has thus far had no cramps and will continue to be observed and added to the Cenogenesis study observations.
L.M. -43 years old- black female with severed cystic mastitis of the breast was started on one spray of Cenogenesis twice daily on March 18, 2000 and immediately noted amelioration of the usual discomfiture in the right breast. She is to be added to the Cenogenesis study observations.
A.J. -51 years old - caucasian female, Somatomedin C (IGF-1) level 117 (90-361 normal range) has history of Hypothyroidism and Menopausal Syndrome with hot flashes, emotional liability, and reduced energy. She was started on Cenogenesis on January 13, 2000, replacing Regenesis Pro which together with Porcine Thyroid had normalized her Thyroid function, and removed the Arrhythmia associated with a prolapsed mitral valve. The addition of Cenogenesis resulted in relief of the menopausal symptoms and an increase in overall energy and sense of well-being. She continued to maintain absence of Arrhythmia of the Mitral Valve Prolapse.
J.L. -42 years old - caucasian female, Somatomedin C (IGF-1) level 179 (normal range 116-270). She had lived with a financially and emotionally stressed environ and associated Chronic Viremias and Chronic Fatigue Syndrome. She started Cenogenesis February 1, 2000 and noted immediately an increase in her capacity to relax and in her overall energy level and sense of well being, which were greatly augmented. She created financial breakthroughs and vacation travel. She was thoroughly enrolled in continuing Cenogenesis, which she has done.
A.P. - 84 years old- caucasian male, IGF-1 (Somatomedin C) on March 12, 2000, 66 ng/ml (normal range 71-290). History of Shingles (Herpes Zoster) with chronic painful residuals in the past year improved with Physiotherapy but unresolved. Started on Cenogenesis March 12, 2000 and within 24 hours was exuberantly extolling his newfound energy, noteworthy strengthening of muscle tone, and attending decrease in Shingle residual discomfiture. He looks forward to continued benefits from Cenogenesis.
F. Pearl McBroom, MD
For more information on growth hormone and Regenesis GH, go to Information for Health Care Professionals (Adobe Acrobat Format). This study is on pages 17-18.
Regenesis makes no medical claims - Statements contained herein have
not been evaluated by the Food and Drug Administration. These products
are not intended to diagnose, treat and cure or prevent disease. Always
consult with your professional health care provider before changing any